Anti-Mullerian Hormone levels after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in breast cancer patients

被引：0
|
作者：
Choi, Y. M. [1 ,2 ]
Shin, J. J. [3 ]
Kim, H. [1 ]
Lee, K. H. [4 ]
Kim, T. Y. [4 ]
Han, W. [5 ]
Im, S. A. [4 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Med Res Ctr, Inst Reprod Med & Populat, Seoul, South Korea
[3] Heryoojae Womens Hosp, Fertil Ctr, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
来源：
HUMAN REPRODUCTION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-430
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [21] Gonadotropin-releasing hormone agonists cotreatment during chemotherapy in borderline ovarian tumor and ovarian cancer patients
    Zhu Hong-lan
    Wang Yan
    Li Xiao-ping
    Wang Chao-hua
    Wang Yue
    Cui Heng
    Wang Jian-liu
    Wei Li-hui
    CHINESE MEDICAL JOURNAL, 2013, 126 (04) : 688 - 691
  • [22] PLASMA GONADOTROPIN AND GONADOTROPIN-RELEASING HORMONE LEVELS AFTER INTRANASAL ADMINISTRATION OF GONADOTROPIN-RELEASING HORMONE
    KATZ, M
    PIMSTONE, BL
    CARR, PJ
    HENDRICKS, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 43 (01): : 215 - 221
  • [23] Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application
    Lambertini, Matteo
    Horicks, Florence
    Del Mastro, Lucia
    Partridge, Ann H.
    Demeestere, Isabelle
    CANCER TREATMENT REVIEWS, 2019, 72 : 65 - 77
  • [24] Ovarian reserve in breast cancer: assessment with anti-Mullerian hormone
    Hamy, Anne-Sophie
    Porcher, Raphael
    Cuvier, Caroline
    Giacchetti, Sylvie
    Schlageter, Marie-Helene
    Coussieu, Christiane
    Gronier, Heloise
    Feugeas, Jean-Paul
    Adoui, Nadir
    Lacorte, Jean-Marc
    Poirot, Catherine
    Habdous, Mohamed
    Espie, Marc
    REPRODUCTIVE BIOMEDICINE ONLINE, 2014, 29 (05) : 573 - 580
  • [25] Pretreatment anti-Mullerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer
    Anderson, Richard A.
    Rosendahl, Mikkel
    Kelsey, Thomas W.
    Cameron, David A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (16) : 3404 - 3411
  • [26] Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients
    Bozza, Claudia
    Puglisi, Fabio
    Lambertini, Matteo
    Osa, Etin-Osa
    Manno, Massimo
    Del Mastro, Lucia
    ENDOCRINE-RELATED CANCER, 2014, 21 (01) : R51 - R65
  • [27] Follicular fluid anti-Mullerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles
    Lee, Jung Ryeol
    Kim, Seok Hyun
    Kim, Sun Mie
    Jee, Byung Chul
    Ku, Seung-Yup
    Suh, Chang Suk
    Choi, Young Min
    Kim, Jung Gu
    Moon, Shin Yong
    FERTILITY AND STERILITY, 2008, 89 (04) : 860 - 867
  • [28] Is Anti-Mullerian Hormone a Marker of Ovarian Reserve in Young Breast Cancer Patients Receiving a GnRH Analog during Chemotherapy?
    Torrisi, Rosalba
    Basilico, Vera
    Giordano, Laura
    Caruso, Michele
    Musolino, Antonino
    Monari, Marta Noemi
    Carnaghi, Carlo
    Santoro, Armando
    BREAST CARE, 2022, 17 (01) : 10 - 15
  • [29] Serum levels of anti-Mullerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study
    Hou, Yanru
    Wang, Lu
    Li, Yian
    Ai, Jiajia
    Tian, Li
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] Gonadotropin-Releasing Hormone Agonists for the Preservation of Ovarian Function During Chemotherapy
    Tomao, Federica
    Panici, Pierluigi Benedetti
    Tomao, Silverio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3310 - 3311
12345